Table 2 Patient characteristics (N = 1227)
From: The relationship between target joints and direct resource use in severe haemophilia
| Age (mean ± SD) | 35.7 ± 14.6 |
|---|---|
| Subtype (%) | |
| Haemophilia A | 949 (77.3%) |
| Haemophilia B | 278 (22.7%) |
| Country (%) | |
| UK | 306 (24.9%) |
| Italy | 271 (22.1%) |
| France | 254 (20.7%) |
| Spain | 206 (16.8%) |
| Germany | 190 (15.5%) |
| Treatment strategy (%) | |
| On-demand | 519 (42.3%) |
| Prophylaxis | 708 (57.7%) |
| Target joints (mean ± SD) | 1.1 ± 1.4 |
| Number of target joints (patient n, %) | |
| Zero | 518 (41.2%) |
| One | 334 (46.4%) |
| Two | 241 (34.0%) |
| Three or more | 139 (19.6%) |
| Location of target joints (patient n, % of target joint cohort) | |
| Exclusively lower body | 371 (52.3%) |
| Exclusively upper body | 186 (26.2%) |
| Upper and lower body | 152 (21.4%) |
|
Surgeries to target joints in the previous 12 months (patient n, % of target joint cohort) | 305 (42.7%) |
| Joint aspiration | 200 (28.0%) |
| Endoscopic examination of joint | 116 (16.2%) |
| Joint fusion | 84 (11.8%) |
| Joint replacement | 64 (9.0%) |
| Destruction/surgical removal of synovium | 56 (7.8%) |